These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 21064136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Vezmar S, Schüsseler P, Becker A, Bode U, Jaehde U.
    Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV.
    J Clin Oncol; 2014 Mar 20; 32(9):949-59. PubMed ID: 24550419
    [Abstract] [Full Text] [Related]

  • 8. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.
    Costea I, Moghrabi A, Laverdiere C, Graziani A, Krajinovic M.
    Haematologica; 2006 Aug 20; 91(8):1113-6. PubMed ID: 16870553
    [Abstract] [Full Text] [Related]

  • 9. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
    Kałużna E, Strauss E, Zając-Spychała O, Gowin E, Świątek-Kościelna B, Nowak J, Fichna M, Mańkowski P, Januszkiewicz-Lewandowska D.
    Eur J Pharmacol; 2015 Dec 15; 769():93-9. PubMed ID: 26528799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.
    Anticancer Res; 2008 Dec 15; 28(5B):3051-4. PubMed ID: 19031955
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V, Ramaglia M, Iannotta A, Crisci S, Indolfi P, Francese M, Affinita MC, Pecoraro G, Napolitano A, Fusco C, Oreste M, Indolfi C, Casale F.
    Cancer Chemother Pharmacol; 2011 Nov 15; 68(5):1339-46. PubMed ID: 21590445
    [Abstract] [Full Text] [Related]

  • 14. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.
    den Hoed MA, Lopez-Lopez E, te Winkel ML, Tissing W, de Rooij JD, Gutierrez-Camino A, Garcia-Orad A, den Boer E, Pieters R, Pluijm SM, de Jonge R, van den Heuvel-Eibrink MM.
    Pharmacogenomics J; 2015 Jun 15; 15(3):248-54. PubMed ID: 25348617
    [Abstract] [Full Text] [Related]

  • 15. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
    Garcia-Puig M, Fons-Estupina MC, Rives-Sola S, Berrueco-Moreno R, Cruz-Martinez O, Campistol J.
    Rev Neurol; 2012 Jun 16; 54(12):712-8. PubMed ID: 22673947
    [Abstract] [Full Text] [Related]

  • 16. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
    Yousef AM, Farhad R, Alshamaseen D, Alsheikh A, Zawiah M, Kadi T.
    Cancer Chemother Pharmacol; 2019 Apr 16; 83(4):755-762. PubMed ID: 30684021
    [Abstract] [Full Text] [Related]

  • 17. Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury.
    Mahadeo KM, Dhall G, Panigrahy A, Lastra C, Ettinger LJ.
    Pediatr Hematol Oncol; 2010 Feb 16; 27(1):46-52. PubMed ID: 20121554
    [Abstract] [Full Text] [Related]

  • 18. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS, Ahmed TM.
    Blood Coagul Fibrinolysis; 2013 Mar 16; 24(2):181-8. PubMed ID: 23183238
    [Abstract] [Full Text] [Related]

  • 19. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.
    Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV.
    J Clin Oncol; 2003 Aug 15; 21(16):3084-91. PubMed ID: 12915598
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
    Zheng MM, Yue LJ, Chen XW, Wen FQ, Li CG, Yang CL, Xie C, Ding H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar 15; 15(3):201-6. PubMed ID: 23498762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.